Traynor Capital Management Inc. Invests $366,000 in Stereotaxis, Inc. (NYSEAMERICAN:STXS)

Traynor Capital Management Inc. acquired a new stake in shares of Stereotaxis, Inc. (NYSEAMERICAN:STXS - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 160,509 shares of the company's stock, valued at approximately $366,000. Traynor Capital Management Inc. owned approximately 0.19% of Stereotaxis as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of the stock. Jane Street Group LLC raised its stake in shares of Stereotaxis by 26.9% in the third quarter. Jane Street Group LLC now owns 29,773 shares of the company's stock worth $61,000 after purchasing an additional 6,313 shares during the last quarter. SG Americas Securities LLC raised its position in Stereotaxis by 39.2% during the 4th quarter. SG Americas Securities LLC now owns 26,360 shares of the company's stock worth $60,000 after buying an additional 7,417 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its stake in Stereotaxis by 10.2% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 167,297 shares of the company's stock valued at $341,000 after acquiring an additional 15,491 shares during the period. State Street Corp lifted its stake in Stereotaxis by 5.7% during the 3rd quarter. State Street Corp now owns 680,612 shares of the company's stock valued at $1,388,000 after acquiring an additional 36,518 shares during the period. Finally, Rhumbline Advisers boosted its holdings in shares of Stereotaxis by 645.6% in the 2nd quarter. Rhumbline Advisers now owns 48,251 shares of the company's stock valued at $88,000 after acquiring an additional 41,780 shares during the last quarter. 45.35% of the stock is owned by hedge funds and other institutional investors.

Stereotaxis Trading Down 0.7 %

STXS stock traded down $0.02 during trading on Friday, hitting $2.20. 110,943 shares of the company traded hands, compared to its average volume of 336,786. Stereotaxis, Inc. has a 1 year low of $1.66 and a 1 year high of $3.29. The stock has a market cap of $185.98 million, a P/E ratio of -7.84 and a beta of 1.55.

Stereotaxis (NYSEAMERICAN:STXS - Get Free Report) last released its quarterly earnings results on Monday, November 11th. The company reported ($0.08) EPS for the quarter, missing the consensus estimate of ($0.05) by ($0.03). Stereotaxis had a negative net margin of 85.79% and a negative return on equity of 162.54%. The firm had revenue of $9.20 million for the quarter, compared to analyst estimates of $6.80 million. On average, research analysts predict that Stereotaxis, Inc. will post -0.26 earnings per share for the current fiscal year.

About Stereotaxis

Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites.